Feedback / Questions
NXC-201 - Immix Biopharma
https://www.globenewswire.com/news-release/2024/05/10/2879674/0/en/Immix-Biopharma-Announces-Positive-NXC-201-Relapsed-Refractory-AL-Amyloidosis-Clinical-Data-in-ASGCT-2024-Late-Breaking-Oral-Presentation.html
May 10, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next